Burrows Scott L

EDGAR CIK 0001853327

Spyre Therapeutics, Inc. - SYRE

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($299,639)
-18,428 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/02/2025
09/03/2025
Sell
-18,428 @ $16.26
 ($299,639) 97,994 (-15.83%) Direct